help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Israel, J. M.
Right arrow Articles by Vincent, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Israel, J. M.
Right arrow Articles by Vincent, J. D.

Endocrinology, Vol 117, 1448-1455, Copyright © 1985 by Endocrine Society

ARTICLES

The electrical properties of isolated human prolactin-secreting adenoma cells and their modification by dopamine

JM Israel, P Jaquet and JD Vincent

Human prolactinoma cells were maintained in culture for a period of at least 8 days and were able to secrete PRL in large amounts. This secretion was inhibited by bromocriptine, an agonist of dopaminergic receptors, in a dose-dependent manner. The cells showed electrical activity (action potentials) which was blocked by inhibitors of calcium current (cobalt, manganese), whereas it was insensitive to blockers of sodium current (tetrodotoxin). At the resting potential of the cell, dopamine induced a hyperpolarizing response such that action potentials no longer occurred. This effect was due to increase of the membrane conductance and depended on the cell potential. The reversal potential of this response was at -100 mV, which suggests the involvement of potassium ions. Bromocriptine and RU 24213, which are strong dopaminergic receptor agonists, both induced responses identical to the dopamine-induced response. The D2 receptor antagonists (haloperidol, domperidone, and spiperone) blocked the dopamine-induced response in a reversible manner. The D1 antagonist of dopaminergic receptors flupentixol had no effect on the dopamine response. It is concluded that the dopamine modulation of electrical activity involving calcium current may be an early important step in the mechanism by which dopamine inhibits PRL release.


This article has been cited by other articles:


Home page
 EndocrinologyHome page
A. D. Taylor, J. G. Philip, C. D. John, P. O. Cover, J. F. Morris, R. J. Flower, and J. C. Buckingham
Annexin 1 (Lipocortin 1) Mediates the Glucocorticoid Inhibition of Cyclic Adenosine 3',5'-Monophosphate-Stimulated Prolactin Secretion
Endocrinology, June 1, 2000; 141(6): 2209 - 2219.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
X. Zhen, K. Uryu, H.-Y. Wang, and E. Friedman
D1 Dopamine Receptor Agonists Mediate Activation of p38 Mitogen-Activated Protein Kinase and c-Jun Amino-Terminal Kinase by a Protein Kinase A-Dependent Mechanism in SK-N-MC Human Neuroblastoma Cells
Mol. Pharmacol., September 1, 1998; 54(3): 453 - 458.
[Abstract] [Full Text]

Home page
 J. Neurophysiol.Home page
A. B. Belousov and A. N. V. D. Pol
Dopamine Inhibition: Enhancement of GABA Activity and Potassium Channel Activation in Hypothalamic and Arcuate Nucleus Neurons
J Neurophysiol, August 1, 1997; 78(2): 674 - 688.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1985 by The Endocrine Society